Metformin: A wonder drug

With proof of anticancer activity, metformin status has gone still up the ladder with the recent evidence of reducing the risk of adverse cardiovascular outcomes in patients with type 2 diabetes compared with sulfonylurea monotherapies. Read more about it here.


Drugs<>Therapeutics<>Big Pharma
impas Natesh Prabhu Administrator & Chief Editor | Clinical Pharmacologist | Diabetic-Sexual Medicine-Regenerative Therapy Consultant | President, Indian Medical Pharmacologists Association